INS and diabetes mellitus: Additionally, in mouse models of type 2 diabetes (i.e., high-fat diet-induced diabetes and streptozotocin-induced diabetes), BAIBA treatment reduced fasting levels of free fatty acids, triglycerides, and low-density lipoproteins, which was associated with a decrease in hepatic lipogenesis and improvements in insulin sensitivity9.